AEQUUS PHARMACEUTICALS INC (AQS.CA) Stock Cash Flow
TSX-V:AQS - TSX Venture Exchange - CA0076361033 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.68M | -2.96M | -3.21M | -1.81M | -1.05M | |||
| Depreciation Amortization | 133.17K | 138.16K | 129.83K | 128.11K | 210.97K | |||
| Change In Working Capital | -34.21K | 415.08K | 445.57K | 28.91K | -521.71K | |||
| Interest Paid | N/A | 8.08K | 98.48K | N/A | N/A | |||
| Taxes Paid | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Other non cash items | 98.17K | 117.50K | 682.06K | 480.36K | 551.19K | |||
| OPERATING CASH FLOW | -2.48M | -2.29M | -1.95M | -1.17M | -804.91K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -4.12K | -12.32K | |||
| Other Investing Activity | N/A | N/A | 0.00 | -503.84K | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | -507.96K | -12.32K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.39M | 2.21M | -189.19K | -147.51K | -103.83K | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 2.55M | 2.16M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.39M | 2.21M | -189.19K | 2.40M | 2.05M | |||
| CHANGE IN CASH | -86.62K | -79.62K | -2.14M | 717.56K | 1.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.48M | -2.29M | -1.95M | -1.17M | -804.91K | |||
| Capital Expenditure | N/A | N/A | 0.00 | -4.12K | -12.32K | |||
| FREE CASH FLOW | -2.48M | -2.29M | -1.95M | -1.18M | -817.23K | |||
All data in CAD